Chugai Pharmaceutical applies for approval of antibody cocktail therapy to treat COVID-19 in Japan
Chugai Pharmaceutical has applied for approval to manufacture and sell an antibody cocktail therapy to treat COVID-19 in Japan.
Chugai Pharmaceutical has applied for approval to manufacture and sell an antibody cocktail therapy to treat COVID-19 in Japan.